Insmed (INSM) PT Raised to $121 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Insmed (INSM) PT Raised to $110 at Evercore ISI
June 11, 2025 5:14 AM EDTEvercore ISI analyst Liisa Bayko raised the price target on Insmed (NASDAQ: INSM) to $110.00 (from $90.00) while maintaining a Outperform rating.
The analyst comments "INSM delivered outstanding data on BOTH PVR & 6MWD, handedly beating our and investor expectations, which were already... More
